25 October 2026
Aspirin dementia signal limited to high platelet-gene score in ASPREE
Among the top 20% of platelet-count genetic scores, 1% of aspirin users developed dementia versus 3.3% on placebo.
The full briefing is in the app.
25 October 2026
Among the top 20% of platelet-count genetic scores, 1% of aspirin users developed dementia versus 3.3% on placebo.
The full briefing is in the app.